Business

Market Impact: Vaccine Stocks Tumble Following Trump's RFK Jr. HHS Nomination
Business

Market Impact: Vaccine Stocks Tumble Following Trump's RFK Jr. HHS Nomination

Pharmaceutical stocks experienced significant declines after President-elect Trump named Robert F. Kennedy Jr. as his choice to lead the Department of Health and Human Services. Major vaccine manufacturers including Pfizer, Moderna, and European counterparts saw their shares drop as markets responded to the appointment of Kennedy, known for his critical stance on vaccines and pharmaceutical industry practices.

Jonathan Reed
Cisco's AI Strategy Could Drive Growth Revival Despite Mixed Results
Business

Cisco's AI Strategy Could Drive Growth Revival Despite Mixed Results

Cisco Systems is positioning itself to leverage artificial intelligence opportunities despite reporting mixed financial results. While revenue and earnings show declining trends, the company's strong product orders and strategic moves into AI infrastructure signal potential growth ahead.

Jonathan Reed
Wall Street bonuses expected to surge up to 35% in year-end payouts
Business

Wall Street bonuses expected to surge up to 35% in year-end payouts

Following a three-year slump, Wall Street is preparing to distribute substantially larger year-end bonuses, with some sectors seeing increases of up to 35%. The surge marks the first industry-wide bonus growth since 2021, though the increases will vary significantly across different financial sectors.

Jonathan Reed
Home Depot Q3 Earnings Analysis: Sales Up 6.6% Despite Market Challenges
Business

Home Depot Q3 Earnings Analysis: Sales Up 6.6% Despite Market Challenges

Home Depot reported Q3 fiscal 2024 earnings with sales reaching $40.2 billion, marking a 6.6% increase year-over-year. The world's largest home improvement retailer maintained steady operating performance despite macroeconomic headwinds, while forecasting continued growth for fiscal 2024.

Jonathan Reed